Advertisement
Canada markets close in 1 hour 18 minutes
  • S&P/TSX

    22,305.27
    +61.93 (+0.28%)
     
  • S&P 500

    5,300.43
    +53.75 (+1.02%)
     
  • DOW

    39,824.63
    +266.52 (+0.67%)
     
  • CAD/USD

    0.7352
    +0.0026 (+0.36%)
     
  • CRUDE OIL

    78.70
    +0.68 (+0.87%)
     
  • Bitcoin CAD

    89,025.51
    +5,605.83 (+6.72%)
     
  • CMC Crypto 200

    1,378.81
    +110.86 (+8.74%)
     
  • GOLD FUTURES

    2,393.10
    +33.20 (+1.41%)
     
  • RUSSELL 2000

    2,105.47
    +19.77 (+0.95%)
     
  • 10-Yr Bond

    4.3560
    -0.0890 (-2.00%)
     
  • NASDAQ

    16,727.93
    +216.75 (+1.31%)
     
  • VOLATILITY

    12.67
    -0.75 (-5.59%)
     
  • FTSE

    8,445.80
    +17.67 (+0.21%)
     
  • NIKKEI 225

    38,385.73
    +29.67 (+0.08%)
     
  • CAD/EUR

    0.6758
    -0.0011 (-0.16%)
     

Here's What Key Metrics Tell Us About RenaissanceRe (RNR) Q1 Earnings

RenaissanceRe (RNR) reported $2.83 billion in revenue for the quarter ended March 2024, representing a year-over-year increase of 46.8%. EPS of $12.18 for the same period compares to $8.16 a year ago.

The reported revenue represents a surprise of +5.96% over the Zacks Consensus Estimate of $2.68 billion. With the consensus EPS estimate being $9.86, the EPS surprise was +23.53%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how RenaissanceRe performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Claims and Claim Expense Ratio: 47.7% versus 49.8% estimated by four analysts on average.

  • Underwriting Expense Ratio: 30.2% versus the four-analyst average estimate of 31.7%.

  • Combined Ratio: 77.9% compared to the 82.2% average estimate based on four analysts.

  • Net Claims and Claim Expense Ratio - calendar year - Casualty and Specialty Segment: 67.1% compared to the 63.8% average estimate based on three analysts.

  • Underwriting Expense Ratio - Casualty and Specialty Segment: 32.5% versus 31.6% estimated by three analysts on average.

  • Combined Ratio - Casualty and Specialty Segment: 99.6% versus the three-analyst average estimate of 95.3%.

  • Revenues- Net premiums earned: $2.44 billion versus the four-analyst average estimate of $2.29 billion. The reported number represents a year-over-year change of +45.4%.

  • Revenues- Equity in earnings (losses) of other ventures: $14.13 million versus the four-analyst average estimate of $6.04 million. The reported number represents a year-over-year change of +48.2%.

  • Revenues- Net investment income: $390.78 million versus the four-analyst average estimate of $384.67 million. The reported number represents a year-over-year change of +53.6%.

  • Net premiums earned- Property: $936.08 million versus the three-analyst average estimate of $816.79 million. The reported number represents a year-over-year change of +36.2%.

  • Net premiums earned- Casualty and Specialty: $1.51 billion versus $1.42 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +51.8% change.

  • Revenues- Other income (loss): -$0.05 million versus $2 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -98.8% change.

View all Key Company Metrics for RenaissanceRe here>>>

Shares of RenaissanceRe have returned -5.7% over the past month versus the Zacks S&P 500 composite's -2.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

RenaissanceRe Holdings Ltd. (RNR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research